We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X04 Nov 22
Listed on Nasdaq, Kura Oncology is engaged in developing small molecule drug candidates for the treatment of cancer